Effect of Methamphetamine on Residual Latent HIV Disease (EMRLHD) Cohort Study
The EMRLHD Cohort Study is based in UCSF Pride Hall at Zuckerberg San Francisco General. Our team is looking at the relationship between HIV, the immune system, and methamphetamine (MA) use. EMRLHD is looking to enroll participants living with HIV on antiretrovirals who have current meth use or no current meth use.
For information on enrollment, contact the study team at [email protected] or (415) 340-2303.